These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 34785530)
1. Estimating the population health burden of Lyme disease in Ontario, Canada: a microsimulation modelling approach. Mac S; Evans GA; Patel SN; Pullenayegum EM; Sander B CMAJ Open; 2021; 9(4):E1005-E1012. PubMed ID: 34785530 [TBL] [Abstract][Full Text] [Related]
2. The health and economic burden of pertussis in Canada: A microsimulation study. McGirr A; Fisman DN; Tuite AR Vaccine; 2019 Nov; 37(49):7240-7247. PubMed ID: 31585727 [TBL] [Abstract][Full Text] [Related]
3. Cost of illness in patients with post-treatment Lyme disease syndrome in Belgium. Willems R; Verhaeghe N; Perronne C; Borgermans L; Annemans L Eur J Public Health; 2023 Aug; 33(4):668-674. PubMed ID: 36972275 [TBL] [Abstract][Full Text] [Related]
4. Healthcare costs and outcomes associated with laboratory-confirmed Lyme disease in Ontario, Canada: A population-based cohort study. Mac S; Evans G; Pullenayegum E; Patel SN; Sander B PLoS One; 2023; 18(6):e0286552. PubMed ID: 37347742 [TBL] [Abstract][Full Text] [Related]
5. Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data. Chung MK; Caboni M; Strandwitz P; D'Onofrio A; Lewis K; Patel CJ EBioMedicine; 2023 Apr; 90():104524. PubMed ID: 36958992 [TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005-2014. Johnson KO; Nelder MP; Russell C; Li Y; Badiani T; Sander B; Sider D; Patel SN PLoS One; 2018; 13(6):e0198509. PubMed ID: 29856831 [TBL] [Abstract][Full Text] [Related]
7. Lyme disease and post-treatment Lyme disease syndrome: the neglected disease in our own backyard. Crowder LA; Yedlin VA; Weinstein ER; Kortte KB; Aucott JN Public Health; 2014 Sep; 128(9):784-91. PubMed ID: 25213101 [TBL] [Abstract][Full Text] [Related]
8. Estimating direct healthcare costs attributable to laboratory-confirmed Lyme disease in Ontario, Canada: A population-based matched cohort study using health administrative data. Shing E; Wang J; Khoo E; Evans GA; Moore S; Nelder MP; Patel SN; Russell C; Sider D; Sander B Zoonoses Public Health; 2019 Jun; 66(4):428-435. PubMed ID: 30665259 [TBL] [Abstract][Full Text] [Related]
9. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Aucott JN; Rebman AW; Crowder LA; Kortte KB Qual Life Res; 2013 Feb; 22(1):75-84. PubMed ID: 22294245 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology of Lyme disease in Pennsylvania 2006-2014 using electronic health records. Moon KA; Pollak J; Hirsch AG; Aucott JN; Nordberg C; Heaney CD; Schwartz BS Ticks Tick Borne Dis; 2019 Feb; 10(2):241-250. PubMed ID: 30420251 [TBL] [Abstract][Full Text] [Related]
11. Health care costs, utilization and patterns of care following Lyme disease. Adrion ER; Aucott J; Lemke KW; Weiner JP PLoS One; 2015; 10(2):e0116767. PubMed ID: 25650808 [TBL] [Abstract][Full Text] [Related]
12. Detection of municipalities at-risk of Lyme disease using passive surveillance of Ixodes scapularis as an early signal: A province-specific indicator in Canada. Gasmi S; Ogden NH; Ripoche M; Leighton PA; Lindsay RL; Nelder MP; Rees E; Bouchard C; Vrbova L; Rusk R; Russell C; Pelcat Y; Mechai S; Kotchi SO; Koffi JK PLoS One; 2019; 14(2):e0212637. PubMed ID: 30779789 [TBL] [Abstract][Full Text] [Related]
13. The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium. Geebelen L; Lernout T; Kabamba-Mukadi B; Saegeman V; Sprong H; Van Gucht S; Beutels P; Speybroeck N; Tersago K Arch Public Health; 2017; 75():42. PubMed ID: 28794875 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology and clinical manifestations of reported Lyme disease cases: Data from the Canadian Lyme disease enhanced surveillance system. Murison K; Wilson CH; Clow KM; Gasmi S; Hatchette TF; Bourgeois AC; Evans GA; Koffi JK PLoS One; 2023; 18(12):e0295909. PubMed ID: 38100405 [TBL] [Abstract][Full Text] [Related]
15. Corneal Collagen Cross-Linking in the Management of Keratoconus in Canada: A Cost-Effectiveness Analysis. Leung VC; Pechlivanoglou P; Chew HF; Hatch W Ophthalmology; 2017 Aug; 124(8):1108-1119. PubMed ID: 28457614 [TBL] [Abstract][Full Text] [Related]
16. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491 [TBL] [Abstract][Full Text] [Related]
17. Cerebral palsy in Canada, 2011-2031: results of a microsimulation modelling study of epidemiological and cost impacts. Amankwah N; Oskoui M; Garner R; Bancej C; Manuel DG; Wall R; Finès P; Bernier J; Tu K; Reimer K Health Promot Chronic Dis Prev Can; 2020 Feb; 40(2):25-37. PubMed ID: 32049464 [TBL] [Abstract][Full Text] [Related]